FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

385114002: Prolonged-release transdermal patch (dose form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3634738017 Prolonged-release transdermal patch (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3634739013 Prolonged-release transdermal patch en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release transdermal patch (dose form) Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Some
Prolonged-release transdermal patch (dose form) Is a Drug patch false Inferred relationship Some
Prolonged-release transdermal patch (dose form) Has dose form intended site (attribute) Transdermal (intended site) true Inferred relationship Some
Prolonged-release transdermal patch (dose form) Is a Transdermal dose form (dose form) true Inferred relationship Some
Prolonged-release transdermal patch (dose form) Has dose form administration method (attribute) Apply (administration method) true Inferred relationship Some
Prolonged-release transdermal patch (dose form) Has dose form transformation (attribute) No transformation true Inferred relationship Some
Prolonged-release transdermal patch (dose form) Has dose form release characteristic (attribute) Prolonged-release (release characteristic) true Inferred relationship Some
Prolonged-release transdermal patch (dose form) Has basic dose form (attribute) Patch (basic dose form) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Capsaicin 179mg/hour transdermal patch Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Buprenorphine 20 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Buprenorphine 10 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Buprenorphine 5microgram/hour transdermal patch Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Nicotine 11mg/24hours patch Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Nicotine 22mg/day patch Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Glyceryl trinitrate 800 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely glyceryl trinitrate 200 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely glyceryl trinitrate 400 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely glyceryl trinitrate 600 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 0.025mg/day patch Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 0.0375mg/day patch Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 0.05mg/day patch Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 0.075mg/day patch Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 0.1mg/day patch Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Scopolamine 0.5mg/24 hr patch Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely glyceryl trinitrate 300 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 0.05mg/norethindrone acetate 0.14mg/day transdermal patch Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 0.05mg/norethindrone acetate 0.25mg/day transdermal patch Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 14mcg/day transdermal patch Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Ethinyl estradiol 0.02mg / norelgestromin 0.15mg per day transdermal patch Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Fentanyl 12 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Selegiline 6mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Selegiline 9mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Selegiline 12mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Rivastigmine 4.6mg/24 hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Rivastigmine 9.5mg/24 hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 0.06mg/day transdermal patch Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 3.125 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 1.042 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 1.563 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely estradiol 1.667 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Rotigotine 83.333 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely estradiol 2.083 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 2.083 microgram/hour and norethindrone acetate 7.083 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely estradiol 3.333 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely estradiol 4.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Hyoscine 13.889 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely fentanyl 25 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Testosterone 104.167 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Buprenorphine 35 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely fentanyl 50 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely buprenorphine 52.5 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely fentanyl 75 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely fentanyl 100 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Rotigotine 166.667 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Glyceryl trinitrate 208.333 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Testosterone 208.333 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely testosterone 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Nicotine 291.667 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely nicotine 312.5 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely glyceryl trinitrate 416.667 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Nicotine 583.333 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Glyceryl trinitrate 625 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Nicotine 625 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely rotigotine 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely nicotine 875 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely nicotine 937.5 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 10.4 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 1.04 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 1.56 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 2.5 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 3.13 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely estradiol 4.17 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form False Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely selegiline 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 2.08 microgram/hour and norethisterone acetate 5.83 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Estradiol 583 nanogram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Selegiline 500 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely oxybutynin 162 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Selegiline 375 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely nicotine 917 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Nicotine 458 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Rivastigmine 192 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Rivastigmine 396 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Rotigotine 125 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Rotigotine 41.667 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Buprenorphine 5 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely nicotine 1.563 milligram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely buprenorphine 15 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some

Reference Sets

GB English

US English

Back to Start